← Open Payments lookup

DOLORES REXACH: Open Payments

NPI 1386987626 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$833 in 38 payments from 11 companies in 2025. Trend: 2023 $1,023 · 2024 $1,695 · 2025 $833

Food & beverage: $833
CompanyPaymentsAmount
ABBVIE INC.13$271
Vanda Pharmaceuticals Inc.4$96
Axsome Therapeutics, Inc.3$87
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$73
Janssen Pharmaceuticals, Inc3$67
Corium, LLC4$60
E.R. Squibb & Sons, L.L.C.2$50
Collegium Pharmaceutical, Inc.2$42
Otsuka America Pharmaceutical, Inc.2$42
Takeda Pharmaceuticals U.S.A., Inc.1$25

Products named: VRAYLAR, Auvelity, CAPLYTA, SPRAVATO, REXULTI, Azstarys, HETLIOZ, COBENFY.

Industry payments across FL — which companies pay providers there.